Ms.Xiaomei Wang

Ms. Wang received her Master’s degree from Peking University. She has worked at the Dalian Center for Disease Control and Prevention, the China Center for Disease Control and Prevention, the Damien Foundation Belgium Beijing Representative office, and TenNor Therapeutics with over 15 years of international project management experience and over 9 years of clinical operations experience. She has been involved in preclinical research and development, IND application, and clinical operations, including data management, statistical analysis, and drug safety management. Mrs. Wang has led the completion of multiple Phase I and Phase II clinical trials in China, Australia, and the United States, and participated in the IND applications and pre-IND communications, as well as preclinical researches for a variety of new drugs in China, Australia, and the United States. Currently, she is responsible for the global clinical operations and regulatory affairs of Keythera Biopharmaceuticals.

Back to ListContact Us